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Pat1 promotes processing body assembly
by enhancing the phase separation of the
DEAD-box ATPase Dhh1 and RNA
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Christopher F Mugler1,2†, Paolo Arosio1, Karsten Weis1*
1ETH Zurich, Zurich, Switzerland; 2University of California, Berkeley, Berkeley,
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Abstract Processing bodies (PBs) are cytoplasmic mRNP granules that assemble via liquid–liquid
phase separation and are implicated in the decay or storage of mRNAs. How PB assembly is
regulated in cells remains unclear. Previously, we identified the ATPase activity of the DEAD-box
protein Dhh1 as a key regulator of PB dynamics and demonstrated that Not1, an activator of the
Dhh1 ATPase and member of the CCR4-NOT deadenylase complex inhibits PB assembly in vivo
(Mugler et al., 2016). Here, we show that the PB component Pat1 antagonizes Not1 and promotes
PB assembly via its direct interaction with Dhh1. Intriguingly, in vivo PB dynamics can be
recapitulated in vitro, since Pat1 enhances the phase separation of Dhh1 and RNA into liquid
droplets, whereas Not1 reverses Pat1-Dhh1-RNA condensation. Overall, our results uncover a
function of Pat1 in promoting the multimerization of Dhh1 on mRNA, thereby aiding the assembly
of large multivalent mRNP granules that are PBs.
DOI: https://doi.org/10.7554/eLife.41415.001
Introduction
Cells are often subjected to severe environmental fluctuations such as nutrient deficiency, tempera-
ture changes or osmotic shock. To cope with stresses, a variety of mechanisms have evolved allow-
ing cells to respond acutely and survive. These include changes in the gene expression program,
which are often driven by robust transcriptional responses. Yet cells must also inactivate old mRNAs
that may interfere with adaptation to the new condition, and therefore, post-transcriptional regula-
tion and RNA turnover are critical to enable rapid changes in gene expression (Ashe et al., 2000;
Mager and Ferreira, 1993).
The post-transcriptional fate of eukaryotic mRNAs is tightly linked to the complement of proteins
that associate with it to form mRNPs (messenger ribonucleoproteins). For example, the presence of
the m7 G cap structure at the 5’ end is crucial for eIF4E binding, while Pab1 binds the 3’ poly-A tail,
both of which protect the mRNA against degradation and promote translation initiation. On the
other hand, mRNA turnover is thought to initiate via deadenylation by the Ccr4/Pop2/Not1 complex
(Muhlrad and Parker, 1992; Sheth and Parker, 2003), followed by cap removal by the decapping
enzyme Dcp1/2 and 5’ 3’ degradation of the transcript by the exonuclease Xrn1 (Coller and Parker,
2004; Larimer and Stevens, 1990). Thus, the processes of mRNA translation and decay are coupled
and act antagonistically (Radhakrishnan et al., 2016; Beelman and Parker, 1994; Schwartz and
Parker, 1999; Schwartz and Parker, 2000; Sun et al., 2012; Hu et al., 2009; Chan et al., 2018)
The balance between mRNA translation and decay is not only temporally but also spatially con-
trolled. For instance in yeast, upon glucose starvation, the majority of cellular translation halts and
untranslated mRNA as well as many factors of the RNA decay machinery concentrate in large cyto-
plasmic mRNP granules, so called processing bodies [PBs] (Brengues et al., 2005; Sheth and
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Parker, 2003; Teixeira et al., 2005). PBs contain major components of the 5’ 3’ RNA decay path-
way, for example Dcp1/2 and Xrn1, as well as activators of decapping - namely, the DEAD-box
ATPase Dhh1, Pat1, Edc3 and the Lsm1-7 complex. PBs presumably form around mRNAs seques-
tered away from active translation, and in support of this, inhibition of translation initiation leads to
induction of PBs (Franks and Lykke-Andersen, 2008; Chan et al., 2018; Teixeira et al., 2005). On
the contrary, inhibition of translation elongation, for example by the drug cycloheximide which traps
mRNA on ribosomes, and prevents their influx into PBs, has the opposite effect and leads to PB dis-
assembly (Teixeira et al., 2005; Mugler et al., 2016).
In consequence, PBs have been implicated in a variety of post-transcriptional processes such as
translational repression (Holmes et al., 2004; Coller and Parker, 2005), mRNA decay (Sheth and
Parker, 2003; Cougot et al., 2008; Mugler et al., 2016), mRNA storage (Brengues et al., 2005;
Bhattacharyya et al., 2006), and in higher eukaryotes, micro RNA-mediated repression (Liu et al.,
2005; Pillai, 2005). PBs and related mRNP granules such as stress granules, P granules in germ cells,
neuronal granules etc. form in a number of different species from yeast to mammals, and in a variety
of cell types and biological contexts, suggesting that these structures are crucial for cellular function
or survival (Barbee et al., 2006; Seydoux and Braun, 2006). Indeed, there is evidence that PBs can
be essential for cell survival under stress. For instance, cells unable to form PBs show a drastic loss in
viability in stationary phase (Ramachandran et al., 2011; Shah et al., 2013). However, the precise
role of PBs in the regulation of gene expression is a matter of debate and in order to understand PB
function it is critical to examine how PBs assemble and are regulated.
Numerous recent studies have shown that PBs are dynamic, membraneless organelles that assem-
ble from a variety of multivalent but weak RNA-protein, protein–protein and RNA-RNA interactions;
a phenomenon called liquid–liquid phase separation (LLPS). The resulting granules are liquid-like,
spherical, dynamic and are dissolved by the alcohol 1,6-hexanediol, all key features of LLPS
(Decker et al., 2007; Fromm et al., 2012; Fromm et al., 2014; Guo and Shorter, 2015;
Mugler et al., 2016; Kroschwald et al., 2015).
Although PB formation occurs via a plethora of multivalent protein–RNA interactions in a redun-
dant fashion (Rao and Parker, 2017), there are key players whose deletion drastically attenuates PB
assembly (Decker et al., 2007; Pilkington and Parker, 2008; Scheller et al., 2007). One such com-
ponent is the highly abundant DEAD-box ATPase Dhh1 (DDX6 in humans). Dhh1 is an enhancer of
decapping and is involved in the translational repression of mRNAs (Carroll et al., 2011; Coller and
Parker, 2005; Fischer and Weis, 2002; Coller et al., 2001). We recently showed that Dhh1 under-
goes phase separation in vitro, and controls PB dynamics in vivo via its RNA-stimulated ATPase activ-
ity whereas the ATPase activator Not1 dissolves Dhh1 droplets in vitro and inhibits PB formation in
vivo. However, whether additional factors assist Dhh1 in promoting PB formation remains to be
determined and is the focus of this study.
One such candidate is the eukaryotic PB component Pat1, an evolutionarily conserved multi-
domain RNA binding protein that, like Dhh1, functions in both translational repression and mRNA
decay (Pilkington and Parker, 2008; Teixeira and Parker, 2007). In yeast, Pat1 acts as a scaffold
that brings together repression and decay factors (Dhh1, Edc3, Lsm1-7, Dcp1/2 etc.) via direct and/
or indirect interactions with mRNPs (Nissan et al., 2010). Dhh1 for example directly binds acidic res-
idues in the N-terminal domain of Pat1, an interaction that is conserved across species (Sharif et al.,
2013; Ozgur and Stoecklin, 2013). Deletion of PAT1 in yeast alters the localization of PB compo-
nents, whereas its overexpression induces the formation of constitutive PBs even in unstressed cells
(Pilkington and Parker, 2008; Coller and Parker, 2005). Furthermore, it was shown that phosphory-
lation of Pat1 by the cAMP-dependent protein kinase A (PKA) inhibits PB formation, and cells
expressing a phospho-mimetic mutant of Pat1 are defective in PB assembly (Ramachandran et al.,
2011). However, the mechanism by which Pat1 regulates PB assembly is unclear.
Here, we demonstrate that Pat1 promotes PB formation via Dhh1, and we show that the interac-
tion between Pat1 and Dhh1 is critical for robust PB assembly in vivo. Using a liquid phase separa-
tion assay, we can recapitulate this function of Pat1 in vitro as addition of recombinant Pat1, but not
of a Pat1 variant that cannot bind Dhh1, enhances phase separation of Dhh1 and RNA. Overall, our
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in vivo and in vitro data suggests that during stress Pat1 antagonizes the inhibitory effect of Not1 on
PB assembly and promotes the multimerization of Dhh1 on mRNA, leading to the formation of PBs.
Results
Constitutive PB formation upon Pat1 overexpression is Dhh1
dependent
The PB components Pat1 and Dhh1 were each previously shown to be required for PB formation in
yeast (Pilkington and Parker, 2008; Ramachandran et al., 2011; Mugler et al., 2016; Rao and
Parker, 2017). To understand the relationship between Pat1 and Dhh1 in the regulation of PB
assembly, we took advantage of the observation that overexpression of Pat1 leads to constitutive
PB formation (Coller and Parker, 2005). This allowed us to characterize their respective regulatory
contributions without external influences such as nutrient starvation signals. As expected, Pat1 over-
expression from its endogenous locus using the galactose promoter in the presence of Dhh1 led to
the formation of constitutive PBs, as visualized by co-localization of Dhh1-GFP and Dcp2-mCherry
foci (Figure 1A). No foci were formed when Pat1 was not overexpressed or when we overexpressed
the human influenza hemagglutinin (HA) tag alone (Figure 1—figure supplement 1A). Notably,
when Pat1 was overexpressed in cells that lack Dhh1, a drastic reduction in the number of PBs was
observed, as visualized by the bona fide PB marker Edc3-GFP and its co-localization with Dcp2-
mCherry (Figure 1A,B). This demonstrates that formation of constitutive PBs upon Pat1 overexpres-
sion requires Dhh1.
Pat1 and Dhh1 interaction is essential for PB assembly
Pat1 is an 88 kDa protein that consists of an N-terminal un-structured domain (Pat1-N) followed by a
proline-rich stretch plus middle domain and a C-terminal globular fold (Pat1-C). The N-terminal
domain of Pat1 directly binds Dhh1’s RecA2 core via a conserved DETF motif (Sharif et al., 2013;
Ozgur and Stoecklin, 2013). Furthermore, Pat1’s C-terminus harbors two serine residues that are
phosphorylated by the cAMP-dependent protein kinase A (PKA) negatively regulating the interac-
tion with Dhh1 and PB formation (Ramachandran et al., 2011).
In order to understand how these Pat1 domains influence LLPS and PB assembly, we wanted to
characterize various Pat1 mutants both in vivo and in vitro. Unfortunately, we were unable to recom-
binantly express functional, full-length Pat1. Based on published crystal structures and in vitro inter-
action studies, we therefore developed a minimal Pat1 construct encompassing both N- and
C-terminal domains that we refer to as Pat1-NC [amino acids: 5–79 (N) and 456–787 (C) connected
with a (GGS)4 linker] (Figure 1C). The N-terminal fragment of Pat1 (amino acids 5–79) was crystal-
lized and shown to directly bind to Dhh1 (Sharif et al., 2013) whereas the C-terminus of Pat1 (amino
acids 456–787) contains the PKA phosphorylation sites and mediates the interaction with the LSM-
complex and RNA (Sharif et al., 2013; Fourati et al., 2014; Charenton et al., 2017;
Ramachandran et al., 2011; Pilkington and Parker, 2008).
To investigate whether this PAT1-NC construct is functional in vivo and behaves similar to wild-
type Pat1, we took advantage of the temperature-sensitive growth defect of a PAT1 deletion mutant
(Fourati et al., 2014). Like full-length Pat1, expression of the PAT1-NC construct fully restored
growth of pat1D cells at 37˚ C (Figure 1—figure supplement 1B and C). In addition, we also tested
if the expression of PAT1-NC is able to rescue the synthetic lethality that was observed in pat1D
edc3D scd6D cells (Fourati et al., 2014). The expression of PAT1-NC rescued the growth phenotype
of pat1D edc3D scd6D cells at 37˚C to a similar extent as achieved by wild-type PAT1 (Figure 1—fig-
ure supplement 1D).
Furthermore, cells expressing the PAT1-NC construct when starved of glucose induced PBs to a
similar level as wild-type PAT1 (Figure 1D,E) indicating full functionality in vivo. The PBs in the
PAT1-NC expressing cells rapidly dissolved upon re-addition of glucose demonstrating that they are
reversible and dynamic rather than anomalous granules (Figure 1D). In addition, Pat1-NC-GFP itself
localized to PBs upon stress in a reversible manner (Figure 1—figure supplement 1E). Finally, when
we overexpressed Pat1-NC using a GAL promoter, robust PBs were induced in the absence of stress
(Figure 1F,G). Taken together our data suggest that the PAT1-NC construct is fully functional in
vivo.
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Figure 1. Constitutive PB formation upon Pat1 overexpression is Dhh1 dependent. (A) Overexpression (OE) of Pat1 leads to constitutive PB formation
but only in the presence of Dhh1. Cells co-expressing the indicated PB components were grown in synthetic complete (SC) raffinose media to
exponential growth phase after which Pat1 was overexpressed via addition of galactose. Cells in both raffinose and galactose were observed by
fluorescence microscopy. In all Pat1 OE strains the endogenous promoter of Pat1 was replaced by the galactose 1–10 promoter (p-GAL-PAT1). Scale
Figure 1 continued on next page
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We next examined whether Pat1-NC can interact with Dhh1 in vitro, and as expected, Pat1-NC
displayed strong binding to full-length Dhh1 in a GST pull down assay (Figure 2A). However, this
interaction was completely abolished for a Pat1-NC variant in which the N-terminal DETF motif was
mutated to four alanines [Pat14A-Dhh1, see Supplementary file 2 table S2B for a list of all mutants
used in this study] (Figure 2A).
We next investigated the effect of the pat14A-Dhh1 mutant in the context of the full-length protein
on PB formation in vivo. While cells expressing pat14A-Dhh1 showed a mild growth defect compared
to the wild type PAT1, they grew significantly better than pat1D cells, indicating that this protein is
at least partially functional (Figure 2—figure supplement 1A). To examine whether the interaction
between Pat1 and Dhh1 is required for PB formation, we monitored PB assembly upon stress in the
absence of glucose in wild-type (PAT1) or the pat14A-Dhh1 background. As expected, the number of
PBs was drastically reduced in the complete absence of Pat1, as visualized by Dhh1-GFP (Figure 2—
figure supplement 1B). Importantly, pat14A-Dhh1 expressing cells also demonstrated a drastic reduc-
tion in PB number compared to cells expressing PAT1 (Figure 2B,C) and the Pat14A-Dhh1-GFP pro-
tein itself showed a significant defect in localizing to PBs (Figure 2D,E).
To assure that the Pat14A-Dhh1 mutant is stably expressed, we checked its protein levels using
Western blotting and observed that the mutant expresses to similar levels as wild-type Pat1 (Fig-
ure 2—figure supplement 1C). Moreover, in the Pat14A-Dhh1 mutant cells, the expression levels of
Dhh1 were comparable to the Dhh1 levels in cells harboring a wild-type copy of Pat1 (Figure 2—fig-
ure supplement 1D). This demonstrates that the defect in PB formation in cells expressing the
Pat14A-Dhh1 binding mutant is specifically due to impaired Pat1 function.
We were unable to overexpress the Pat14A-Dhh1 mutant in yeast. In order to investigate PB forma-
tion independently of carbon starvation stress, we therefore treated cells with the drug hippurista-
nol, which inhibits the eukaryotic translation initiation factor eIF4A (Bordeleau, M.E., et al., 2006). In
consequence, hippuristanol prevents translation initiation and robustly induces PB formation within
minutes in cells expressing wild-type PAT1 (Chan et al., 2018) [Figure 2F, Video 1]. Cells expressing
pat14A-Dhh1 however, did not show PB formation until 2 hrs after hippuristanol addition (Figure 2F
and Video 2).
It cannot be excluded that the Pat14A-Dhh1 mutant might interfere with the binding of Pat1 to
some other factor with a role in PB formation in addition to Dhh1. We therefore also employed a
complementary approach wherein we examined mutants on Dhh1 that impair interaction with Pat1.
Two such Dhh1 mutants have been described: Dhh1 Mut3A (Dhh1S292DN294D) and Dhh1 Mut3B
(Dhh1R295D) that partially or completely abolish binding to Pat1, respectively (Sharif et al., 2013).
Cells expressing either wild-type Dhh1, Dhh1S292DN294D, Dhh1R295D or lacking Dhh1 altogether were
starved of glucose and PB assembly was assessed. Whereas the Dhh1 variants expressed as well as
wild-type Dhh1 (Figure 3—figure supplement 1), we observed a drastic reduction in the number of
PBs in both Dhh1S292DN294D, Dhh1 R295D cells (Figure 3A,B), and as published before also in dhh1D
cells (Figure 3A,B, Mugler et al., 2016). The Dhh1R295D had a more severe PB formation defect
Figure 1 continued
bar: 5 mm. (B) Quantification of images in A depicting number of PBs/cell. N = 3 biological replicates with >800 cells/replicate. Error bars: SEM. (C)
Pat1-NC (AA 5–79 + 456–587) is functional in vivo. Cartoon of the Pat1-NC construct (see text for details). (D) PAT1-NC induces PB formation upon
stress in vivo. Cells co-expressing the indicated the PB components in PAT1 full length or PAT1-NC background were grown in synthetic complete
(SCD) media to exponential growth phase then shifted to glucose-rich or glucose-starvation conditions for 30 min and observed by fluorescence
microscopy. PBs induced in the PAT1-NC background were dissolved by addition of 2% glucose demonstrating reversibility. Scale bar: 5 mm. (E)
Quantification of images shown in A depicting number of PBs/cell. Bars: SEM. N = 3 biological replicates with >800 cells/replicate. (F) PAT1-NC (AA 5–
79 + 456–587) OE leads to constitutive PB induction. p(GAL)-PAT1 or p(GAL)-PAT1-NC cells expressing Dhh1-GFP were grown in SC raffinose media to
exponential growth phase after which Pat1 OE was induced with galactose. Scale bar: 5 mm. (G) Graph depicts Dhh1 PBs/cell, SEM. N = 3 biological
replicates with >800 cells/replicate. [Diatrack 3.05 and cell segmentation using in house Matlab code was used for the quantification of PB and cell
numbers respectively for all the experiments shown in the manuscript].
DOI: https://doi.org/10.7554/eLife.41415.002
The following figure supplement is available for figure 1:
Figure supplement 1. Controls for Pat1 OE related to Figure 1 and growth rescue experiments of Pat1-NC.
DOI: https://doi.org/10.7554/eLife.41415.003
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Figure 2. Pat1-Dhh1 interaction is essential for PB assembly. (A) Recombinant Pat1-NC4A-Dhh1 is defective for Dhh1 binding. GST pull-down with GST-
Pat1-NC and mutants thereof as matrix-bound bait and Dhh1 as prey. After 1 hr of binding at 4˚C, the samples were washed five times with a buffer
containing 300 mM NaCl and visualized by Coomassie staining after separation on a 12% acrylamide gel. (B) Expression of pat1 4A-Dhh1 (Dhh1 binding
mutant) leads to a drastic reduction in PB formation. Cells co-expressing the indicated PB components in the PAT1 or pat14A-Dhh1 background were
Figure 2 continued on next page
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compared to the Dhh1S292DN294D aligning with the in vitro binding abilities of these Dhh1 mutants to
Pat1 (Sharif et al., 2013).
To test PB formation independently of carbon starvation stress in these Pat1-binding mutants of
Dhh1, we used the drug hippuristanol as before. Dhh1 wild-type cells when treated with hippurista-
nol formed PBs within minutes as judged by the co-localization of Dhh1-GFP and Dcp2-mCherry foci
(Figure 3C,D and Video 3). However, both the Dhh1S292DN294Dand Dhh1R295D mutants did not form
robust PBs until 3 hrs of hippuristanol treatment exhibiting a phenotype similar to dhh1D cells
(Figure 3C,D and Videos 4, 5 and 6). Taken together, our data reveal that the Pat1-Dhh1 interaction
is pivotal for robust PB assembly.
Pat1 phosphorylation status influences RNA binding
Pat1 is a target of the cAMP-dependent protein kinase A (PKA) and phosphorylation of two serines
(amino acids 456/457) in the C-terminus of Pat1 under glucose-rich conditions was previously shown
to negatively regulate PB formation (Ramachandran et al., 2011). In agreement with the published
literature, cells expressing the pat1EE mutant showed a defect in PB formation (Figure 4—figure
supplement 1A,B and Ramachandran et al., 2011). To better understand how Pat1 phosphoryla-
tion controls PB assembly, we sought to characterize the influence of the phosphorylation status of
Pat1 on PB formation in the absence of stress. Overexpression of PAT1WT/SS (WT = wild type) and
pat1AA (non-phosphorylatable) led to constitutive PB formation as visualized by Dhh1-GFP and
Dcp2-mCherry positive foci. However, upon overexpression of pat1EE (phospho-mimetic), foci num-
ber was reduced (Figure 4A,B). The Pat1EE-GFP mutant was expressed as well as wild-type Pat1-
GFP and had no effect on Dhh1 expression (Figure 2—figure supplement 1C and D) emphasizing
that the phospho-mimetic mutant specifically impairs Pat1 function.
Pull-down experiments from cell extracts previously suggested that PKA-dependent phosphoryla-
tion of Pat1 diminishes its interaction with Dhh1
(Ramachandran et al., 2011). To test whether
this effect is direct, we performed pull-down
assays with the recombinant Pat1-NC protein
and the Pat1-NCEE variant. However, in this
assay there was no significant difference in Dhh1
binding between Pat1-NC and Pat1-NCEE
(Figure 2A). Since the strong DETF binding site
in Pat1-N might mask any weaker interaction in
Pat1-C, we also tested for direct binding of
Pat1-C to Dhh1 but were unable to detect any
interaction (Figure 4C), indicating that the
DETF-motif in Pat1-N provides the major interac-
tion surface for Dhh1.
Figure 2 continued
grown in SCD media to exponential growth phase, then shifted to glucose-rich or glucose-starvation conditions for 30 min and observed by
fluorescence microscopy. Scale bar: 5 mm. (C) Quantification of images in B depicting number of PBs/cell, (Dhh1-GFP PBs co-localizing with Dcp2-
mCherry) are shown, three biological replicates, bars: SEM. (D) Pat14A-Dhh1-GFP mutant is defective for PB localization. Cells expressing either Pat1-GFP
or the Pat14A-Dhh1-GFP mutant were grown in SCD media to exponential growth phase then shifted to glucose-rich or glucose-starvation conditions for
30 min and observed by fluorescence microscopy. Scale bar: 5 mm. (E) Quantification of images shown in D depicting number of PBs/cell. N = 3
biological replicates with >500 cells/replicate. Error bars: SEM. (F) pat14A-Dhh1 mutant is defective in PB formation upon hippuristanol treatment. Cells
expressing either PAT1 or the pat14A-Dhh1 were grown in SCD media to exponential growth phase after which they were treated with 10 mM
hippuristanol for 2 hrs. The kinetics of PB formation was monitored using Dhh1-GFP and its co-localization with Dcp2-mCherry. Quantification of PBs/
cell is depicted. Stills from the live imaging time course are shown. N = 2 biological replicates, two technical replicates each with >300 cells/replicate,
SD.
DOI: https://doi.org/10.7554/eLife.41415.004
The following figure supplement is available for figure 2:
Figure supplement 1. Expression levels of various Pat1 mutants used in this study and their growth phenotypes.
DOI: https://doi.org/10.7554/eLife.41415.005
Video 1. Hippuristanol induces PBs in cells expressing
wild-type PAT1. The video depicts PB formation (Dhh1-
GFP and Dcp2-mCherry co-localization) in cells
expressing wild-type PAT1 upon hippuristanol
treatment. (2 hr video, 5 min intervals; video played at
seven fps). Each frame is a single plane.
DOI: https://doi.org/10.7554/eLife.41415.006
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Pat1-C was previously shown to bind RNA
(Pilkington and Parker, 2008;
Chowdhury et al., 2014). We therefore tested
whether RNA binding is regulated by PKA-
dependent phoshphorylation by performing
RNA oligo gel shift assays using recombinant
proteins. Whereas wild-type Pat1-C robustly
binds the RNA oligo and shifts it to higher
molecular weight in a native PAGE gel, Pat1EE
displayed a significantly reduced RNA shift
(quantified in Figure 4D). Taken together, our in
vivo and in vitro results on the phospho-mimetic
Pat1EE mutant suggest that in addition to Pat1-
Dhh1 binding, also the interaction between Pat1
and RNA is important for PB formation.
Pat1 and Not1 act antagonistically
in vivo
Our lab previously showed that Not1 promotes PB disassembly by activating the ATPase activity of
Dhh1, and cells expressing a Not1 mutant that cannot bind to Dhh1 (not19X-Dhh1) form constitutive
PBs in non-stressed cells. Yet these PBs are less intense and fewer in number than those formed
upon glucose starvation (Mugler et al., 2016), indicating that additional mechanisms prevent PB for-
mation in glucose-replete conditions.
Since in glucose-rich media PB assembly is also inhibited by the PKA-dependent phosphorylation
of Pat1 (Ramachandran et al., 2011), we wanted to test whether expression of the non-phosphory-
latable pat1AA variant enhances PB formation in the not19X-Dhh1 strain background. While expression
of pat1AA alone was not sufficient to induce constitutive PBs as observed before
(Ramachandran et al., 2011) and Figure 4—figure supplement 1A,B), expression of pat1AA in the
presence of not19X-Dhh1 significantly increased the number of constitutive PBs compared to cells
expressing not19X-Dhh1 alone (Figure 5A and B). Yet, these PBs are still not as bright and numerous
as in stressed wild-type cells. Interestingly, PB intensity strongly increased when these strains were
further treated with hippuristanol, a drug that blocks initiation and liberates mRNA molecules from
polysomes. The percentage of large PBs was highest in the pat1AA + not199X-Dhh1 strain, followed
by the not19X-Dhh1 and then pat1AA (Figure 5A,B).
Overall, this suggests that there are at least three determinants that act cooperatively to enhance
the formation of PBs: (a) direct interactions between Pat1-Dhh1 and Pat1-RNA; (b) lack of Not1 bind-
ing to Dhh1 and in consequence low Dhh1 ATPase activity (Mugler et al., 2016); and (c) the avail-
ability of PB client mRNAs that are not engaged in translation. Furthermore, our results suggest that
Pat1 and Not1 act antagonistically on PB dynamics. Whereas Pat1 binding to Dhh1 enhances the
assembly of PBs, the interaction of Not1 with Dhh1 promotes PB disassembly, likely through activa-
tion of the ATPase activity of Dhh1.
Pat1 promotes PB assembly by enhancing the phase separation of
Dhh1 and RNA
At least two mechanisms of how Pat1 promotes PB formation via Dhh1 could be envisioned: first,
Pat1 could slow the ATPase cycle of Dhh1, for example by preventing Not1 binding and/or inhibiting
ATP hydrolysis, second, Pat1 could directly promote oligomerization and condensation of Dhh1 on
RNA.
To test the first hypothesis, we used an in vitro ATPase assay using purified protein components
in which Not1 robustly stimulates the ATPase activity of Dhh1 (Mugler et al., 2016). However, we
did not observe a significant inhibition of the Not1-stimulated ATPase activity upon addition of
Pat1-NC (Figure 6—figure supplement 1A), suggesting that Pat1 does not directly interfere with
the mechanism of ATPase activation.
We had previously shown that PB dynamics are regulated by the ATPase activity of Dhh1
(Carroll et al., 2011; Mugler et al., 2016). To test Pat1’s effect on the Dhh1 ATPase cycle in vivo,
Video 2. Hippuristanol fails to induce PBs in cells
expressing pat14A-Dhh1 mutant. The video depicts
failure to form PBs (Dhh1-GFP and Dcp2-mCherry co-
localization) in cells expressing pat14A-Dhh1 upon
hippuristanol treatment. (2 hr video, 5 min intervals;
video played at seven fps). Each frame is a single
plane.
DOI: https://doi.org/10.7554/eLife.41415.007
Sachdev et al. eLife 2019;8:e41415. DOI: https://doi.org/10.7554/eLife.41415 8 of 27
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Figure 3. Dhh1R295D and Dhh1S292DN294D (Pat1 binding mutants) are defective in PB formation. (A) Expression of two distinct Pat1 binding mutants,
Dhh1R295D and Dhh1S292DN294D, leads to a drastic reduction in PB formation. Cells co-expressing the indicated PB components in either Dhh1,
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Figure 3 continued on next page
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we therefore also examined the turnover of PBs that form upon Pat1 overexpression. The drug
cycloheximide (CHX) traps mRNAs on polysomes and thereby stops the supply of new RNA clients
to PBs. Since active Dhh1 constantly releases mRNA molecules from PBs, a lack of mRNA influx
eventually leads to their disassembly and in consequence the catalytic dead mutant of Dhh1 that is
locked in the ATP- state (Dhh1DQAD) inhibits PB disassembly and was shown to have negligible turn-
over rates (Mugler et al., 2016; Kroschwald et al., 2015). We observed that PBs formed upon Pat1
overexpression were more dynamic than PBs formed in the presence of Dhh1DQAD and their disas-
sembly kinetics was comparable to PBs formed upon stress in a wild-type DHH1 background (Fig-
ure 6—figure supplement 1B,C and Videos 7, 8 and 9). Thus, overall, our in vitro and in vivo
findings are not consistent with the conclusion that Pat1 blocks the ATPase activation of Dhh1.
The second hypothesis is that Pat1 promotes higher-order mRNP assembly by directly or indi-
rectly promoting Dhh1 oligomerization, thereby acting as a scaffold and providing additional pro-
tein–protein or protein-RNA interactions (Coller and Parker, 2005; Rao and Parker, 2017). We
have previously shown that recombinant Dhh1 can undergo LLPS in the presence of RNA and ATP,
and that these Dhh1 droplets can recapitulate aspects of in vivo PB dynamics. (Mugler et al., 2016).
We therefore utilized this in vitro system to test Pat1’s impact on the phase separation behavior of
Dhh1.
Dhh1 droplets were assembled from purified components as described previously (Mugler et al.,
2016). Interestingly, while no LLPS of Pat1-NC alone was detected (Figure 6—figure supplement
2A), addition of increasing concentrations of wild-type Pat1-NC strongly enhanced the LLPS of Dhh1
in the presence of ATP and RNA as judged by an increase in the area * intensity of Dhh1 droplets
(Figure 6A). Furthermore, Pat1-NC itself enriched in Dhh1 droplets, suggesting that Pat1 and Dhh1
co-oligomerize with RNA to form a composite phase-separated compartment (Figure 6A).
In order to test if the enhancement in phase separation of Dhh1 via Pat1 is RNA-dependent, we
perfomed this experiment also in the absence of RNA. Interestingly, we did not observe any Dhh1
droplets upon addition of increasing concentrations of Pat1-NC when RNA was omitted from the
reaction (Figure 6—figure supplement 2B) suggesting that under these in vitro conditions RNA
plays a critical role in the Pat1-promoted enhancement of Dhh1 oligomerization and higher-order
phase separation. Consistent with this, the Pat1-N- terminus alone which cannot bind to RNA also
does not enhance the phase separation of Dhh1
even in the presence of RNA and ATP (Fig-
ure 6—figure supplement 2C).
Overall, our in vitro data suggests that a com-
bination of both the Pat1-N (binding to Dhh1)
and Pat1-C (binding to RNA) is critically required
to enhance the phase separation of Dhh1 and
promote higher-order oligomeric mRNP struc-
tures akin to in vivo PBs.
To test the specificity of LLPS stimulation, we
tested the Pat14A-Dhh1 (Dhh1 binding) and Pat1EE
(phospho-mimetic) mutants both of which drasti-
cally reduce PB formation in vivo (see
Figures 2B and 4A,B and Figure 4—figure sup-
plement 1A). Consistent with the in vivo results,
Figure 3 continued
positive PBs/cell; N = 4 biological replicates with >300 cells/replicate, SEM. (C) Dhh1R295D and Dhh1S292DN294D mutants are defective in PB formation
upon hippuristanol treatment. Cells expressing either Dhh1, Dhh1R295D, Dhh1S292DN294D or dhh1D, were grown in SCD media to exponential growth
phase after which they were treated with 10 mM hippuristanol for 3 hrs. The kinetics of PB formation was monitored using Dhh1-GFP and its co-
localization with Dcp2-mCherry. (D) Quantification of PBs/cell. Stills from the live imaging time course are shown. N = 3 biological replicates with >300
cells/replicate, SEM.
DOI: https://doi.org/10.7554/eLife.41415.008
The following figure supplement is available for figure 3:
Figure supplement 1. Dhh1 mutants that abolish Pat1 binding are expressed at similar levels to wild-type Dhh1.
DOI: https://doi.org/10.7554/eLife.41415.009
Video 3. Hippuristanol induces PBs in cells expressing
wild-type Dhh1. The video depicts PB formation (Dhh1-
GFP and Dcp2-mCherry co-localization) in cells
expressing wild-type Dhh1 upon hippuristanol
treatment. (3 hr video, 5 min intervals; video played at
seven fps). Each frame is a single plane.
DOI: https://doi.org/10.7554/eLife.41415.010
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Dhh1-RNA droplet formation was either not at all or only mildly stimulated upon addition of these
Pat1 variants (Figure 6A).
We previously demonstrated that the MIF4G domain of Not1 prevents formation of Dhh1-RNA
droplets, presumably by activating the ATPase cycle of Dhh1 (Mugler et al., 2016). We therefore
next analyzed whether the Pat1-Dhh1 droplets are still responsive to Not1. Similar to what we
observed in vivo (Figure 5), Not1MIF4G also diminishes formation Dhh1 droplets in the presence of
Pat1 in vitro (Figure 6B).
Taken together our results suggest that Pat1 enhances the multivalency of protein–protein and
protein-RNA interactions in a Dhh1-Pat1 mRNP and in consequence promotes the formation of
higher-order, liquid-like mRNP droplets akin to in vivo PBs.
In vitro phase separated droplets mimic the stoichiometry of PB
components in vivo
To examine how well our in vitro droplets resemble in vivo PBs we investigated the stoichiometric
ratio of Dhh1:Pat1 in these granules. In order to
determine the stoichiometry in vivo, we mea-
sured the number of PBs and the fluorescence
intensity of GFP-tagged Dhh1 and Pat1 in these
foci. Briefly, we glucose starved both Pat1-GFP
and Dhh1-GFP expressing cells to induce PBs
(Figure 7—figure supplement 1A) and used the
single particle tracking software Diatrack to
count the number and intensity of PBs in an
unbiased and automated manner in each strain
(Vallotton et al., 2017). Surprisingly, despite the
fact that the cellular concentration of Pat1 is ten-
times lower than Dhh1 (Figure 7—figure sup-
plement 1B), the ratio of the two PB compo-
nents was approximately 2:1 ± 0.18 (Dhh1:Pat1)
after 0.5–4 hr of starvation (Figure 7A).
Extended starvation resulted in enhanced Dhh1
recruitment to PBs until reaching a Dhh1:Pat1
ratio of 2.5:1 ± 0.23, suggesting that PB compo-
sition matures over time (Figure 7A).
In order to determine the stoichiometry of
Pat1 and Dhh1 droplets in vitro, we imaged
Dhh1-mCherry and Pat1-GFP droplets with a
confocal microscope (Figure 7—figure supple-
ment 1C). The protein concentration of both
Dhh1 and Pat1 in the droplet was calculated
Video 4. Hippuristanol does not induce PBs in cells
expressing the Dhh1S292DN294D mutant. The video
depicts PB formation (Dhh1S292DN294D -GFP and Dcp2-
mCherry co-localization) in cells expressing the
Dhh1S292DN294D mutant upon hippuristanol treatment.
(3 hr video, 5 min intervals; video played at seven fps).
Each frame is a single plane.
DOI: https://doi.org/10.7554/eLife.41415.011
Video 5. Hippuristanol fails to induce PBs in cells
expressing the Dhh1R295D mutant. The video depicts PB
formation (Dhh1R295D-GFP and Dcp2-mCherry co-
localization) in cells expressing the Dhh1R295D mutant
upon hippuristanol treatment. (3 hr video, 5 min
intervals; video played at seven fps). Each frame is a
single plane.
DOI: https://doi.org/10.7554/eLife.41415.012
Video 6. dhh1D cells do not form PBs upon
hippuristanol treatment. The video depicts PB
formation (Dcp2-mCherry co-localization) in cells
lacking dhh1 upon hippuristanol treatment. (3 hr video,
5 min intervals; video played at seven fps). Each frame
is a single plane.
DOI: https://doi.org/10.7554/eLife.41415.013
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Figure 4. Overexpression (OE) of PAT1WT (wild-type) and pat1AA (non- phosphorylatable) leads to constitutive PB formation but OE
of pat1EE (phospho-mimetic) does not and the Pat1-CEE mutant weakens Pat1-RNA binding. (A) Cells co-expressing the indicated PB components were
grown in SC raffinose media to exponential growth phase after which OE of different Pat1 alleles was induced by galactose addition. Cells were
imaged using fluorescence microscopy. (B) Quantification of images shown in A depicting number of PBs/cell. Scale bar: 5 mm, SEM. N = 3 biological
Figure 4 continued on next page
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from a standard curve determined from values measured for different concentrations of the respec-
tive soluble fluorophores (Figure 7B). Remarkably, we found a stoichiometric ratio of 2.7:1 ± 0.13 of
Dhh1 to Pat1 in the in vitro phase-separated droplets, closely resembling the Dhh1:Pat1 ratio of
mature PBs in vivo (Figure 7B).
Thus, while other mRNA decay factors also contribute to PB formation in vivo, our data demon-
strate that with a minimal number of constituents, namely Dhh1, RNA, ATP and Pat1 higher-order
dynamic liquid droplets can be formed in vitro. The in vitro droplets recapitulate various properties
of PBs formed in vivo such as (a) the stoichiometry of PB components, and (b) the dynamics of Pat1-
stimulated assembly and Not1-stimulated disassembly of in vivo PBs identifying Pat1 as an important
player in PB formation promoting LLPS via Dhh1.
Discussion
Tug-of-war model between Pat1 and Not1 to regulate PB dynamics
The ability of proteins and RNA to undergo LLPS has emerged as an essential fundamental biologi-
cal process allowing cells to organize and concentrate their cellular components without the use of
membranes. Yet, how these membraneless organelles assemble, are kept dynamic and are regulated
remains enigmatic. One such cellular phase-separated compartment is the PB and our results pre-
sented here together with our prior work (Mugler et al., 2016) identify and characterize both posi-
tive and negative regulators of PB assembly and provides novel insight into the regulation of
membraneless organelle formation.
Overall, our work uncovers a function of Pat1 as an enhancer of PB formation that acts via Dhh1
and counteracts the inhibitory function of Not1. Based on our results, we propose that there are at
least three inputs that cooperatively regulate PB dynamics in vivo (Figure 7C). First, the availability
of mRNA clients acting as seeding substrates to initiate PB formation. mRNA availability is inversely
proportional to the translation status, which is regulated by different stress responses and the meta-
bolic state of the cell (Figure 2C). Second, the activity of cAMP-dependent PKA negatively regulates
PB assembly in nutrient-rich conditions, at least in part through phosphorylation of Pat1. However,
since expression of non-phosphorylatable Pat1AA at endogenous levels (in contrast to overexpres-
sion) is not sufficient to induce PBs, Pat1 availability appears to be limiting (Figures 5 and 4A, and
Figure 4—figure supplement 1A and Ramachandran et al., 2011). Third, activation of the Dhh1
ATPase cycle by the CCR4-Not1 deadenylation complex stimulates mRNA release and negatively
regulates PB assembly. It is of note that Not1 itself might also be subject to post-translational regu-
lation, in response to metabolic state and/or cell cycle stages of the cell (Mugler et al., 2016;
Braun et al., 2014).
In this model, a tug-of-war between Pat1 and Not1 regulates PB assembly and disassembly:
whereas a tight Pat1-Dhh1 interaction in the presence of RNA clients, promotes PB formation, Not1,
induces PB turnover via stimulating the ATPase activity of the DEAD box ATPase Dhh1 (Figure 7C).
Remarkably, our in vivo findings are corroborated in vitro wherein, Pat1 enhances the LLPS of Dhh1
and RNA, a step critical for the assembly of large mRNP granules, and by contrast, Not1 reverses
Figure 4 continued
replicates with >800 cells/replicate. (C) Pat1-C-terminal domain does not bind Dhh1. V5 pull-down with V5-Pat1-C and V5-Pat1-CEE as matrix-bound
bait and Dhh1-mCherry as prey. After 1 hr of binding at 4˚C, the samples were washed four times with a buffer containing NaCl as indicated and
visualized by Coomassie staining after separation on a 12% acrylamide gel. (D) Pat1-CEE weakens the interaction with RNA compared to Pat1-C.
Recombinant Pat1-C (WT) and Pat1-CEE were incubated with a Cy5-labeld 29nt RNA oligo in the presence of 300 mM NaCl and separated on a
NativePage gradient gel. The fluorescence of the oligo was detected by LI-COR imaging. Reactions were performed in triplicate and the intensity of
the upper shifted RNA oligo band was quantified. Equal input of the Pat1-C proteins was verified by acrylamide PAGE and Coomassie staining. Error
bars: SD.
DOI: https://doi.org/10.7554/eLife.41415.014
The following figure supplement is available for figure 4:
Figure supplement 1. PAT1 and pat1AA lead to PB induction upon stress, which is drastically reduced in the pat1EE background.
DOI: https://doi.org/10.7554/eLife.41415.015
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the LLPS of Pat1-Dhh1-RNA droplets (Figures 6 and 7C). Furthermore, the observed stoichiometry
of Dhh1 and Pat1 in PBs is recapitulated in our in vitro phase separation assay (Figure 7A,B).
The interaction between Pat1 and Dhh1 is critical for PB assembly
Inducing PB formation by Pat1 overexpression or hippuristanol treatment allowed us to dissect dis-
tinct mechanisms that govern PB assembly and characterize the crucial role of the Pat1-Dhh1 interac-
tion in this process. The benefit of these modes of PB formation are that they bypass the
characteristic stresses associated with PB formation, such as nutrient starvation, that might have
more widespread and confounding effects on translation, mRNA degradation, or on the regulation
of other PB components.
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Figure 5. not19X-Dhh1 (Dhh1 binding mutant) combined with pat1AA (non-phosphorylatable Pat1) enhances constitutive PB formation in the absence of
stress. (A) Cells expressing either not19X-Dhh1 or pat1AA or the combination of both mutants were grown in SCD media to exponential growth phase
and PBs visualized by fluorescence microscopy using Dcp2-mCherry as a bona fide PB marker. Scale bar: 5 mm. (B) The graph depicts the number of
Dcp2 positive PBs/cell. N = 3 biological replicates with >500 cells visualized in each replicate, bars: SEM.
DOI: https://doi.org/10.7554/eLife.41415.016
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Our experiments reveal that Pat1 functions in
PB formation through Dhh1 since PB induction by Pat1 overexpression is strictly dependent on the
presence of Dhh1 (Figure 1A). Furthermore, a mutant in the DETF motif in the N-terminus of Pat1
mediating direct binding to Dhh1 (Pat14A-Dhh1 variant) and mutants of Dhh1 that abolish Pat1 bind-
ing fail to promote PB assembly (Figure 2). These results were further confirmed using the drug hip-
puristanol that inhibits translation initiation wherein PBs were induced in wild-type cells but not in
cells expressing the Pat14A-Dhh1 mutant, and the Dhh1 mutants that abolish Pat1 binding (Dhh1R295D
and Dhh1 S292DN294D) [Figures 2F and 3C and Chan et al., 2018]. This suggests that high mRNA
load alone is inadequate for PB formation and that a direct physical interaction between Pat1 and
Dhh1 is obligatory as well. Since the DETF motif in Pat1 is conserved across evolution and was sug-
gested to regulate PB assembly in human cells as well (Sharif et al., 2013; Ozgur and Stoecklin,
2013), the Pat1-Dhh1 interaction likely plays a critical role in PB formation across species.
Our results seem to be at odds with a previous publication, which suggests that Pat1 acts inde-
pendently of Dhh1 to promote PB formation (Coller and Parker, 2005). However, in this study Pat1
was overexpressed from a plasmid, in the presence of the endogenous copy. When recapitulating
these conditions, we observed that PB components mislocalize to the nucleus [observed by DAPI
and a nuclear rim marker, see Figure 7—figure supplement 2A,B] and it is possible that in the
absence of additional organelle markers, this nuclear accumulation was misinterpreted as PB
formation.
Pat1 enhances the LLPS of Dhh1, thereby promoting PB formation
How does Pat1 enhance PB formation? One hypothesis is that Pat1 directly counteracts the Not1-
stimulated ATPase activation of Dhh1, but we do not favor such a model since i) Pat1 does not
inhibit Dhh1’s ATPase activity at physiological protein ratios in vitro (Figure 6—figure supplement
1A), ii) Not1MIF4G dissolves Pat1-Dhh1 condensates, while droplets formed from catalytic-dead
Dhh1DQAD are Not1-resistant (Figure 6 and Mugler et al., 2016), and iii) in vivo, PBs formed upon
Video 7. Cycloheximide treatment causes wild-type PB
disassembly. Dcp2-mCherry expressing cells in the
DHH1 background were grown in (SC) raffinose media
to exponential growth phase, after which galactose was
added to 2% final concentration for 2 hr and then
starved for 30 mins to allow PBs to form. The cells were
then treated with 50 mg/mL cycloheximide for 90 min
and disappearance of foci was monitored using
fluorescence microscopy. (5 min intervals; video played
at seven fps). Each frame is a single plane.
DOI: https://doi.org/10.7554/eLife.41415.017
Video 8. Cycloheximide treatment causes Pat1 OE PB
disassembly albeit faster than PB disassembly in cells
expressing dhh1 DQAD. Cells expressing Dcp2-mCherry
in the p(GAL)-PAT1 OE strain were grown in (SC)
raffinose to exponential growth phase, after which
galactose was added to 2% final concentration for 2 hr
to allow PBs to form. Thereafter, the cells were treated
with 50 mg/mL cycloheximide (CHX) for 90 min and
disappearance of foci was monitored using
fluorescence microscopy. (5 min intervals; video played
at seven fps). Each frame is a single plane.
DOI: https://doi.org/10.7554/eLife.41415.018
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Pat1 overexpression are much more dynamic
than those formed from Dhh1DQAD (Figure 7—
figure supplement 1B).
Instead, our data are consistent with a model
in which Pat1 promotes PB assembly by directly
enhancing the LLPS of Dhh1. DDX6, the human
homolog of Dhh1 can oligomerize (Ernoult-
Lange et al., 2012), and given the fact that both
DDX6 and Dhh1 are found in molar excess over
mRNA, we propose that Pat1 functions as a scaf-
fold, providing additional multivalent interactions
with Dhh1 and RNA, thereby aiding in the fusion
of Dhh1 LLPS droplets and promoting assembly
of microscopically-detectable mRNP condensates
(Figure 6). Interestingly, both functional binding
to Dhh1 in Pat1-N and RNA-binding in Pat1-C
are required for this mechanism as individually
mutations in each of the domains alter PB assem-
bly in vivo and fail to enhance Dhh1’s phase sepa-
ration in vitro. Rather, Pat1-N alone diminishes
the extent of LLPS (Figure 6—figure supplement
2C). It is interesting to note that Pat1-N was pre-
viously shown to interfere with the ability of Dhh1
to interact with RNA (Sharif et al., 2013) and we
thus speculate that Pat1-N might outcompete
RNA from Dhh1, and in the absence of the C-ter-
minal Pat1 RNA-binding site destabilize droplets.
This might explain why RNA-binding by Pat1’s
C-terminus that is under the regulation of PKA
(Figure 4A,B, Figure 4—figure supplement 1A)
is critical for LLPS and PB assembly. In vivo, we
find that the Pat14A-Dhh1 (Dhh1 binding mutant) and Pat1EE (phospho-mimetic mutant) not only have
a drastically reduced number of PBs, but also much lower intensity (reduced by 7 and 8 fold respec-
tively, Figure 7—figure supplement 2C) compared to Pat1 wild-type PBs.
Our recent findings also show that the un-structured poly-Q rich C-terminal tail of Dhh1 is
required for PB formation in vivo and Dhh1 LLPS in vitro (Hondele et al., submitted). Thus, Pat1
might potentially enhance Dhh1 multimerization via the low complexity tails of Dhh1. Structural stud-
ies will now be needed to clarify how Pat1 facilitates oligomerization and PB formation of the Dhh1-
Pat1- RNA complex.
The emerging importance of LLPS in diverse aspects of cell biology and
the power of in vitro reconstitution systems
As non-membrane bound organelles, it is of interest to understand how cells assemble large RNP
granules and regulate their dynamics. PBs are prominent membraneless cellular compartments,
which have been shown to be not only involved in numerous aspects of mRNA turnover, but also
crucial for survival under various cellular stresses. With an in vitro phase separation tool in hand that
faithfully reconstitutes certain aspects of PB formation, we are now in a position to dissect how PBs
form and characterize their biophysical behavior. This will aid us not only in elucidating key compo-
nents of PB formation, but also help us elucidate the function of PBs in regulating mRNA turnover.
At this stage, our in vitro systems are limited to Dhh1, Pat1, Not1 and RNA and for the sake of
simplicity; we present a model only depicting the role of Pat1 and Dhh1 in PB formation
(Figure 7C). However, it is important to note that several additional PB components have been char-
acterized. For example, this includes Ecd3, members of the Lsm1-7 complex, or Dcp2 that play cru-
cial roles either alone or together with Pat1 and Dhh1 in PB assembly. Both Edc3 and Lsm4 contain
low complexity-domains that were shown to be critical for PB formation in vivo, and it was recently
demonstrated a threshold concentration of low-complexity domain containing proteins is required
Video 9. Cycloheximide treatment of dhh1 DQAD PBs.
Dcp2-mCherry expressing cells in the dhh1DQAD
mutant background were grown in (SC) raffinose to
exponential growth phase, after which galactose was
added to 2% final concentration for 2 hr. The cells were
then carbon starved for 30 min to allow PBs to form
after which, 50 mg/mL cycloheximide was added and
disappearance of foci was monitored for 90 mins using
fluorescence microscopy. (5 min intervals; video played
at seven fps). Each frame is a single plane.
DOI: https://doi.org/10.7554/eLife.41415.019
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Figure 6. Pat1 WT but not Pat14A-Dhh1/EE mutant enhances the phase separation of Dhh1 and RNA in vitro. (A) 4 mM Dhh1-mCherry was mixed with 3.2
mM ATP and 0.2 mg/ml polyU as RNA-analog in a 150 mM KCl buffer. Pat1-NC-GFP and mutants thereof were added in increasing concentrations, as
indicated. mCherry and GFP intensities are scaled identically in all images displayed. Representative images, scale bar 25 mm. Quantification of the
droplet intensity multiplied by area (mCherry and GFP channels separately normalized to Dhh1 alone and Pat1 4 mM, respectively) of three technical
Figure 6 continued on next page
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for robust PB assembly (Protter et al., 2018). In addition, it was previously shown that both Pat1 (C-
terminus) and the Lsm1-7 complex individually have low RNA binding ability but a reconstituted
Lsm1-7-Pat1-C complex displays an enhanced ability to bind RNA (Chowdhury et al., 2014). This
might suggest that in vivo the Pat1-C- terminus functions together with the Lsm1-7 complex to bind
RNA and enhance PB formation. Furthermore, it cannot be excluded that direct binding of Dcp2 to
the C-terminus of Pat1 also regulates PB assembly and RNA turnover (Fourati et al., 2014). It will
thus be critical to examine additional PB components in future experiments and to evaluate how
they function together with Pat1 and Dhh1 in order to understand the complex interplay of various
inputs that regulate PB assembly and dynamics. Nonetheless, based on our data and the aforemen-
tioned literature evidence, we propose that Pat1 provides a central PB scaffold and participates in
an intricate network of protein–protein and protein-RNA interactions that promote PB assembly and
influence RNA turnover rates in vivo.
The physical basis of LLPS has attracted a great deal of attention recently, at least in part because
of the critical role that proper mRNP assembly plays in pathological neurodegenerative diseases and
stress responses (Ramaswami et al., 2013; Alberti and Hyman, 2016; Patel et al., 2015;
Aguzzi and Altmeyer, 2016; Hyman et al., 2014). An important challenge is to understand how
these granules are kept dynamic and functional under some conditions whereas the formation of
solidified and aberrant aggregates are triggered under others. Robust in vitro reconstitution systems
that can recapitulate mRNP granule assembly, dynamics and stoichiometry will be invaluable in
addressing these research questions and increase our understanding of the molecular mechanism of
how cells age and deal with stress.
Materials and methods
Key resources table
Reagent type
(species) or
resource Designation Source or reference Identifiers
Additional
information
Strain, strain
background
(Yeast:
Saccharomyces
cerevisiae)
W303 SGD:https://www.
yeastgenome.org
/strain/S000203491
KWY XYZ MATa/MATa
{leu2-3,112
trp1-1 can1-100
ura3-1 ade2-1
his3-11,15} [phi+]
Strain, strain
background
(Escherichia coli)
E.Coli DH5a Thermo
Fisher Scientific
18258012
Strain, strain
background
(Escherichia coli)
E.Coli BL21 star (DE3) Thermo
Fisher Scientific
C601003
Genetic
reagent ()
Please see
Supplementary file 1, 2—S2A
Antibody mouse-anti-GFP Roche Cat# 11814460001,
RRID: AB_390913
Western blot:
1:1000
Continued on next page
Figure 6 continued
replicates of the reactions displayed in Figure 5A, mean and standard deviation. (B) Not1 prevents droplet formation also in the presence of Pat1.
Proteins were mixed as indicated, and droplet formation induced by addition of low salt buffer, ATP and polyU. Scale bar 25 mM, quantification
(intensity multiplied by area) of two biological replicates (one to three technical replicates each), mean and standard deviation.
DOI: https://doi.org/10.7554/eLife.41415.020
The following figure supplements are available for figure 6:
Figure supplement 1. Pat1 does not slow down the ATPase cycle of Dhh1.
DOI: https://doi.org/10.7554/eLife.41415.021
Figure supplement 2. Pat1 does not phase separate in vitro and the enhancement of Dhh1’s phase separation via Pat1 is RNA dependent.
DOI: https://doi.org/10.7554/eLife.41415.022
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Continued
Reagent type
(species) or
resource Designation Source or reference Identifiers
Additional
information
Antibody rabbit-anti-Hxk1 US Biological Cat# H2035-01,
RRID: AB_2629457,
Salem, MA
Western blot:
1:3000
Antibody IRdye 680RD
goat-anti-rabbit
LI-COR Biosciences Cat# 926–68071,
RRID: AB_10956166
Western blot:
1:5000
Antibody IRdye 800
donkey-anti-mouse
LI-COR Biosciences Cat# 926–32212,
RRID: AB_621847
Western blot:
1:10000
Antibody Rabbit-anti-Dhh1 in house #100 Western blot:
1:5000
Recombinant
DNA reagent
Please
see
Supplementary
file 2—table S2B
Chemical
compound, drug
hippuristanol kind gift from Junichi
Tanaka, University
of the Ryukyus
hippuristanol 10 mM in
DMSO
Chemical
compound, drug
cyclohexi Sigma-Aldrich, CH CAS Number 66-81-9 50 ug/ml in
DMSO
Software,
algorithm
Diatrack http://www.diatrack.org/ Diatrack used for
counting PB
number
and intensity
Software fiji/imagej NIH https://fiji.sc/ adjusting
brightness,
contrast and
making final
figures
The details regarding all the yeast strains used in this study are in Supplementary file 1.
Supplementary file 2—table S2A contains all the plasmids used in this study. Table Supplementary
S2B contains the mutants used in this study and Supplementary file 2—table S2C describes the
entire DNA oligos used for this manuscript.
Construction of yeast strains and plasmids
S. cerevisiae strains used in this study are derivatives of W303 and are described in
Supplementary file 1. ORF deletion strains and C-terminal epitope tagging of ORFs was done by
PCR-based homologous recombination, as previously described (Longtine et al., 1998). Plasmids
for this study are described in Supplementary file 2—table S2A. Mutations in Pat1 were generated
by introducing the mutation in the primer used to amplify the respective Pat1 regions and stitched
together with the selection marker from the plasmid (Supplementary file 2—table S2B). Mutations
in Dhh1 and Not1 were generated as in Mugler et al. (2016). Primer sequences for strain construc-
tion are listed in table S2C.
Overexpression of Pat1 wild-type and mutants
The samples were grown overnight in synthetic media containing 2% raffinose, diluted to
OD600 = 0.05 or 0.1 the following day, and grown to mid-log phase (OD600 = 0.3–0.4). The culture
was split into two and to one-half galactose was added to 2% final concentration and the corre-
sponding protein induced for 2–3 hr. The cells in both raffinose and galactose were imaged using a
wide-field fluorescence microscope.
PB induction and disassembly kinetics
PBs were induced via glucose starvation stress. Samples were grown overnight in synthetic media
containing 2% glucose, diluted to OD600 = 0.05 or 0.1 the following day, and grown to mid-log
phase (OD600 = 0.3–0.8). Cells were harvested by centrifugation and washed in ¼ volume of fresh
Sachdev et al. eLife 2019;8:e41415. DOI: https://doi.org/10.7554/eLife.41415 19 of 27
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Figure 7. Stoichiometry of Pat1 and Dhh1 in PBs in vivo and in liquid droplets in vitro. (A) Pat1-GFP and Dhh1-GFP expressing cells were grown in SCD
media to exponential growth phase and then shifted to SC (minus glucose) for the indicated time points. PB formation was visualized by fluorescence
microscopy. Graph depicts the ratio of Dhh1: Pat1 in PBs in vivo. N = 3 biological replicates, SEM. (B) Calibration curves to determine the protein
concentration of Dhh1-mCherry and Pat1-NC-GFP within the droplets: the fluorescence intensity of homogeneous solutions of the respective proteins
Figure 7 continued on next page
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synthetic media ± 2% glucose, then harvested again and re-suspended in 1 vol of fresh synthetic
media ± 2% glucose and grown 30 min at 30˚C. Cells were then transferred onto Concanavalin
A-treated MatTek dishes (MatTek Corp., Ashland, MA) and visualized at room temperature. For
cycloheximide experiments, final concentration of 50 ug/mL (Sigma-Aldrich, CH) were used to exam-
ine PB disassembly kinetics. For PB induction and to determine the kinetics of PB assembly we used
hippuristanol (a generous gift of Junichi Tanaka, University of the Ryukyus) at a final concentration of
10 mM.
Wide-field fluorescence microscopy
Cells were transferred onto Concanavalin A-treated MatTek dishes (MatTek Corp., Ashland, MA)
and visualized at room temperature Microscopy was performed using an inverted epi-fluorescence
microscope (Nikon Ti) equipped with a Spectra X LED light source and a Hamamatsu Flash 4.0
sCMOS camera using a 100x Plan-Apo objective NA 1.4 and the NIS Elements software. Representa-
tive images were processed using ImageJ software. Brightness and contrast were adjusted to the
same values for images belonging to the same experiment and were chosen to cover the whole
range of signal intensities. Image processing for PB analysis was performed using Diatrack 3.05 parti-
cle tracking software (Vallotton and Olivier, 2013) as described below.
Automated image analysis for PB quantification
In order to quantify PB formation in live cells, we used an automated image analysis in a manner sim-
ilar to Mugler et al. (2016). First, PBs were counted using Diatrack 3.05 particle tracking software
using local intensity maxima detection, followed by particle selection by intensity thresholding and
particle selection by contrast thresholding with a value of 5% (Vallotton et al., 2017). To speed up
the analysis, we renamed all our images in a form that can be recognized as a time-lapse sequence
by Diatrack, and placed them all in a single directory, such that they all will be analyzed using exactly
the same image analysis parameters. Renaming and copying was done by a custom script
(Source Code 1), which also performed cell segmentation using a method adapted from
(Hadjidemetriou et al., 2008). Briefly, the method first detects all edges using a Laplacian edge
detection step, and then traces normals to those edges in a systematic manner. These normals tend
to meet at the cell centre where the high density of normals is detected, serving as seeds to recon-
struct genuine cells. Our script thus counts cells and reports their number for each image - informa-
tion which is output to an excel table. The results from Diatrack PB counting are imported from a
text file into that table, and the number of PB is divided by the number of cells for each image.
Protein purification
Dhh1 and Not1 were purified as described previously (Mugler et al., 2016). V5-Pat1-C, GST-Pat1-N
and GST-Pat1-NC constructs as described in Supplementary file 2—table S2A were cloned into
pETM-CN vectors. These expression vectors were transformed into chemically competent E. coli
BL21 DE3 under the selection of ampicillin and chloramphenicol. Pre-cultures were grown in LB at
Figure 7 continued
was measured at different protein concentrations (blue circles). The unknown protein concentration was determined by linear fitting of this calibration
curve (violet circle). Confocal fluorescence microscopy images of phase-separated droplets of Dhh1-mCherry in the absence and presence of Pat1-GFP
are shown. Scale bar: 20 mM. (C) Tug-of-war model between Pat1 and Not1 to regulate PB dynamics. Model depicting three inputs that cooperatively
regulate PB formation. The solid black arrows on the left show interaction between the Pat1 N-terminus with the RecA2 core of Dhh1, Pat1 C-terminus
with RNA, Dhh1 interaction with RNA and potential Dhh1-Dhh1 interactions via low-complexity unstructured tails. The dotted grey arrows on the right
demonstrate multivalent interactions in a PB driven by the LLPS of Dhh1 and RNA (a process enhanced by Pat1). Colors: green: inputs that promote PB
assembly, red factors that negatively regulate PB formation. Violet: Dhh1, light green: Pat1-NC, blue: RNA.
DOI: https://doi.org/10.7554/eLife.41415.023
The following figure supplements are available for figure 7:
Figure supplement 1. Images and protein expression levels related to stoichiometry of Pat1 and Dhh1 in PBs in vivo and in liquid droplets in vitro.
DOI: https://doi.org/10.7554/eLife.41415.024
Figure supplement 2. OE of Pat1 in the presence of the endogenous copy of Pat1 [p-PAT1 +p(GAL)-PAT1] leads to the nuclear localization of PB
components.
DOI: https://doi.org/10.7554/eLife.41415.025
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37˚C over-night, and diluted 1:100 into rich medium the next morning. Cells were grown at 37˚C to
an OD600 of 0.6 and induced with 200 mM IPTG (final concentration). Cells were then grown over-
night at 18˚C, harvested and resuspended in 30 mL lysis buffer (500 mM (Pat1-C, Pat1-N) or 300 mM
NaCl (Pat1-NC), 25 mM Tris-HCl pH 7.5, 10 mM imidazole, protease inhibitors, 10% glycerol) per
cell pellet from 2 L of culture. After cell lysis by EmulsiFlex (Avestin Inc, Ottawa, CA), the 6xHis
tagged proteins were affinity extracted with Ni2+ sepharose in small columns, dialyzed into storage
buffer (MH200G (Pat1-C, Pat1-N): 200 mM NaCl, 25 mM Tris pH 7.5 (RT), 10% glycerol, 2 mM DTT),
MH300G (Pat1-NC): same with 300 mM NaCl) with simultaneous protease cleavage of the His-tag
and GST-tag (unless required for pull-down assays) and further purified by size exclusion with a
Superdex 200 column on an AEKTA purifier (both GE Life Sciences, Marlborough, MA) in storage
buffer. Protein expression levels, His eluates and gel filtration fractions were analyzed by SDS-PAGE.
Clean Superdex elution fractions were pooled, concentrated using Millipore Amicon Centrifugation
units and snap frozen as ~20 ml aliquots in siliconized tubes in liquid nitrogen.
ATPase assays
ATPase assays were performed according as described (Montpetit et al., 2011) with the following
modifications: final concentration 2 mM Dhh1-mCherry was mixed with 0.5 mM Not1 and Pat1-
mCherry (1 and 3 mM) as indicated and protein volumes equalized with storage buffer (MH200G). 2
mL 10x ATPase buffer (300 mM HEPES-KOH pH 7.5, 1 M NaCl, 20 mM MgCl2), 4 mL 10 mg/ml polyU
(unless indicated otherwise), RNase inhibitors, 13.3 mL 60% glycerol, 2.7 mL 10 mg/mL BSA, were
added to a final volume of 36 mL. Reactions were set up in triplicate in a 96-well NUNC plate. The
assay was initiated by the addition of 40 mL of a master mix containing 1x ATPase buffer, 2.5 mM
ATP (from a 100 mM stock in 0.5 M HEPES-KOH pH 7.5), 1 mM DTT, 6 mM phosphoenolpyruvate,
1.2 mM NADH (from a 12 mM stock in 25 mM HEPES-KOH pH 7.5) and 125–250 units/mL PK/LDH.
NADH absorption was monitored with a CLARIOstar plate reader (BMG Labtech, Ortenberg, Ger-
many) at 340 nm in 30 s intervals for 400 cycles.
In vitro liquid droplet reconstitution assay
Reactions were pipetted in 384-well microscopy plates (Brooks 384 well ClearBottom Matriplate,
low glass). Proteins were diluted to 50 mM (Dhh1) or 100 mM (Not1, Pat1) stocks with storage buffer
and mixed as droplets at the side of the well; volumes were equalized to 5 ml with storage buffer.
Next, a master mix of 12.5 ml 150 mM KCl buffer (150 mM KCl, 30 mM HEPES-KOH pH 7.4, 2 mM
MgCl2), 2 ml ATP reconstitution mix (40 mM ATP, 40 mM MgCl2, 200 mM creatine phosphate, 70 U/
mL creatine kinase), 2.5 ml 2 mg/ml polyU (in H2O) as an RNA analog, 1 ml 1M HEPES-KOH pH 6.4
buffer and 2 ml 10 mg/ml BSA were added and mixed by pipetting, the droplets still at the side of
the well, since this later on produced more equal droplet distribution. First imaging was performed
after 20 min incubation at room temperature; just prior to imaging, droplets were spun down at 100
g for 1 min. For subsequent analysis, plates were stored in the fridge. Pictures displayed were
recorded after 1 hr incubation.
Stoichiometry analysis of Dhh1 and Pat1 in PBs in vivo
In order to estimate the relative amount of Dhh1 to that of Pat1 in PBs in vivo, we labelled both pro-
teins with eYGFP in two separate strains, and imaged them in exactly the same conditions after
inducing carbon (glucose) starvation stress for indicated times (Figure 6A). Using exactly the same
endogenous probe for both proteins allowed us to deduce ratios of abundances directly from ratios
of intensities (no spectral corrections are necessary). We then measured the intensity of the 10
brightest PBs as a function of time and in both cases took the median intensity value as representa-
tive of the more visible PBs (at least 10 PBs were present in every image for both strains and at each
time point). Finally, we divided the median value obtained for Dhh1 by that for Pat1 and plotted
that ratio as a function of time post-stress.
Stoichiometry of Dhh1 and Pat1 in phase-separated in vitro droplets
For the analysis of the in vitro phase transition of Dhh1 in the presence of Pat1, 2 mM mCherry-
tagged Dhh1 and 4 mM GFP-tagged Pat1-NC were added to 0.1 mg/ml polyU and 5 mM ATP in 150
mM KCl, 30 mM HEPES-KOH, pH 7.4 and 2 mM MgCl2. After 1 hr incubation, the phase-separated
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droplets were imaged in both the mCherry and the GFP channel by confocal fluorescence micros-
copy (Leica TCS SP8) with a 63x NA 1.4 oil objective (Leica). The protein concentration was evalu-
ated from the fluorescence intensity via a standard curve obtained by measuring a series of samples
at different known concentrations for each fluorophore. The size distributions were obtained by ana-
lyzing the images obtained by fluorescence microscopy with an in-house code written in Matlab.
GST pull-down assays
25 ml of 100 mM recombinant purified GST Pat1-NC was bound to 30 ml GST-slurry (Sigma), and one
aliquot of GST-beads was included without added Pat1-NC as negative control. Reactions were incu-
bated for 30mins rotating at 4˚C and washed 4-times with wash buffer (300 mM NaCl, 10 mM Tris
pH 7.5, 0.05 % NP40). 4 ml 250 mM Dhh1 was added in 500 ml wash buffer and incubated rotating at
4˚C for 1 hr. Reactions were washed 5-times, proteins eluted by boiling with 4x SDS loading buffer
and separated on a 12% acrylamide gel and stained with Coomassie. For V5-pulldown assays, the
bait (15 ml 100 mM Pat1-C construct) was bound to 15 ml V5-slurry (Sigma), the bait 3 ml 200 mM
Dhh1-mCherry, and incubation/wash buffers as above with salt concentration as indicated in the
blot. Final washes were only performed three times.
Native PAGE
Proteins were diluted to 20 mM. 0, 2 or 4 ml of protein solution was filled to 4 ml with storage buffer
(200 mM NaCl, 25 mM Tris pH 7.5, 10% glycerol, 2 mM DTT). Proteins were mixed with a master
mix containing per reaction 2 ml 10x ATPase buffer (300 mM HEPES-KOH pH 7.5, 1 M NaCl, 20 mM
MgCl2), 0.3 ml Cy5-labeled in vitro transcribed RNA oligo (29nt, 1.1 mg/ml), 2 ml 2.5M NaCl, 13.7 ml
H2O and 3 ml 60% glycerol. Reactions were incubated on ice for 20 min and separated on a precast
Bis-Tris Native gradient Gel (Invitrogen) in 1x running buffer (50 mM Bis-Tris 50 mM Tricine pH 6.8)
at 100V 4˚C for about 2.5 hr.
Growth curve and spotting assays
Overnight yeast cultures were grown in permissive conditions in SCD media. Growth curves were
acquired using CLARIOstar automated plate reader (BMG Labtech, Ortenberg, Germany) at 30˚C in
24-well plastic dishes (Thermo Fisher) from overnight pre-cultures diluted 1:125 in the specified syn-
thetic liquid media. For spotting assays on plates the indicated strains were grown overnight at 25˚C
to saturation. Next day equal number of ODs for each strain was spotted (with a 1:10 series dilution)
on YPD plates and incubated at 25˚C, 30˚C and 37˚C for 2–3 overnights.
Western blotting
For Western blot analysis, roughly 5 OD600 units of log growing cells were harvested and treated
with 0.1M NaOH for 15 mins at room temperature. The samples were vortexed in between and
finally centrifuged to remove the NaOH. SDS sample buffer was added and homogenates were
boiled. Proteins were resolved by 4–12% Bolt Bis-Tris SDS PAGE (Thermo Fischer, Waltham, MA),
then transferred to nitrocellulose membrane (GE Life Sciences, Marlborough, MA). Membranes were
blocked in PBS with 5% non-fat milk, followed by incubation with primary antibody overnight. Mem-
branes were washed four times with PBS with 0.1% Tween-20 (PBS-T) and incubated with secondary
antibody for 45 min. Membranes were imaged and protein bands quantified using an infrared imag-
ing system (Odyssey; LI-COR Biosciences, Lincoln, NE). The following primary antibodies were used
for detection of tagged proteins at the indicated dilutions: rabbit-anti-Dhh1 (1:5000) as described in
(Fischer and Weis, 2002), (Weis Lab ETH Zurich Cat# Weis_001, RRID:AB_2629458), mouse-anti-
GFP (1:1000) (Roche Cat# 11814460001, RRID:AB_390913), and rabbit-anti-Hxk1 (1:3000) (US Bio-
logical Cat# H2035-01, RRID:AB_2629457, Salem, MA). IRdye 680RD goat-anti-rabbit (LI-COR Bio-
sciences Cat# 926–68071, RRID:AB_10956166) and IRdye 800 donkey-anti-mouse (LI-COR
Biosciences Cat# 926–32212, RRID:AB_621847) were used as secondary antibodies.
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